💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueLearn More

EVOQ Remedies Ltd (EVOQ)

BSE
Currency in INR
Disclaimer
9.40
+0.52(+5.86%)
Delayed Data
EVOQ Scorecard
Full Analysis
High shareholder yield
Fair Value
Day's Range
8.889.40
52 wk Range
8.5019.44
Bid/Ask
9.03 / 9.40
Prev. Close
8.88
Open
9.14
Day's Range
8.88-9.4
52 wk Range
8.5-19.44
Volume
40,000
Average Volume (3m)
45,133
1-Year Change
-41.19%
Fair Value
Unlock
Fair Value Upside
Unlock
EVOQ Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

EVOQ Remedies Ltd Company Profile

Evoq Remedies Limited engages in the marketing, trading, and distribution of pharmaceutical formulations in India. The company trades in sweeteners, such as acesulfame potassium, aspartem, dextrose, erythritol, euro vanillin powder, malodextrin, miglitol, neotame, pharma sugar; amino acids, such as L- alanine, L-arginine, L-aspartic acid, L-carnitine, L-cystine, L-glutamic acids, L-glutamine, L-glutathione, L-glycine, L-isoleucine, L-lavine, L-leucine, L-ornathene, L-aspartate, L-phenylamine, L-serine, L-threonine, L-trytophan, L-tyrosine, L-lysine, N-acetyl, and L-andystine; excipients, which include aspartem, bronopol, cross carmellous sodium, cross povidone, ethyl olliate, hard peraffin, hpmc all grades, light liquid paraffin, mannitol, menthol crystal, etc.; neutraceuticals, such as alpha lipoic acid, astaxanthin, bacopa benfothiamine, betacarotene, biotin, bonistein, bovine colostrum powder, etc.; and opthalamics, which include atropine sulphate, bimatoprost, brimonidine, bromfenac, cyclopentolate, dorzolamide fluoromethelone, flurbiprofen, gatifloxacin, ketorolac tromethamine, latanoprost, loteprednol etabonate, moxifloxacin, natamycin, nepafenac, olopatadine, sulphacetamide sodium, timolol meleate, etc. It also offers ointments, such as adapalene, allantoin, avobenzone, azealic acid beclomethasone di propionate, betamethasone and salts, calamine, chlorocresol, citrimide clindamycin phoshphate, clobetasol propionate, clotrimazole, cyclosporine, fluocinolol acetonide, fusidic acid, gamabenzene, gentamycin sulphate, halobetasol, hydroquinone, etc.; and oncology drugs, such as abiraterone acetate, alfuzosin, anastrazole, axitinib azacitidine, bicalutamide, bleomycin, bosutinib, busualphan cabazitaxel amphorous, capcitabine, carboplatin, cisplatin, etc. In addition, the company offers vitamins, dairy and spice products, sterile, active pharmaceutical ingredients, and veterinary feed products. The company was incorporated in 2010 and is based in Ahmedabad, India.

Employees
0
Market
India

Compare EVOQ to Peers and Sector

Metrics to compare
EVOQ
Peers
Sector
Relationship
P/E Ratio
48.9x31.8x−0.6x
PEG Ratio
9.690.240.00
Price/Book
0.9x4.5x2.6x
Price / LTM Sales
3.5x2.8x3.1x
Upside (Analyst Target)
-−1.1%56.2%
Fair Value Upside
Unlock−14.6%7.7%Unlock

FAQ

What Is the EVOQ Remedies (EVOQ) Stock Price Today?

The EVOQ Remedies stock price today is 9.40.

What Stock Exchange Does EVOQ Remedies Trade On?

EVOQ Remedies is listed and trades on the BSE stock exchange.

What Is the Stock Symbol for EVOQ Remedies?

The stock symbol for EVOQ Remedies is "EVOQ."

What Is the EVOQ Remedies Market Cap?

As of today, EVOQ Remedies market cap is 221.11M.

What is EVOQ Remedies Earnings Per Share?

The EVOQ Remedies EPS is 1.25.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.